Il Yang Bio Talipl Tablet (Taninflumate)

Adult dosage

Administer talniflumate 370 mg orally 3 times daily. In severe cases, administer 740 mg per dose. The dose may be adjusted as appropriate according to age and symptoms.

This medication may cause gastrointestinal bleeding if taken by individuals who regularly consume more than three drinks per day; consultation with a doctor or pharmacist is essential. This medication may increase the risk of cardiovascular disease, so patients with a history of heart disease or stroke, or those with risk factors, should exercise special caution. Serious gastrointestinal adverse reactions, such as gastrointestinal bleeding, ulcers, or perforations, may occur, especially in the elderly or individuals with a history of gastrointestinal disorders. Patients with peptic ulcers or allergies to any components of this medication should not use it, and pregnant or breastfeeding women should avoid taking it. Patients with weakened liver or kidney function, or diminished heart function, should use this medication cautiously, and the elderly should be attentive to adverse reactions when taking it. During treatment, hypersensitivity reactions may occur such as nausea, vomiting, abdominal pain, skin rashes, and difficulty breathing; if any abnormal symptoms arise, medical personnel should be notified immediately. This medication may increase blood pressure or worsen symptoms of heart failure; patients with hypertension or heart failure should closely monitor blood pressure and symptoms before and after taking it. Long-term use requires regular liver and kidney function tests, and blood tests to check for abnormalities. This medication may interact with other non-steroidal anti-inflammatory drugs, anticoagulants, diuretics, lithium, methotrexate, etc.; be sure to inform your healthcare provider if you are taking other medications. In late pregnancy, it can be harmful to the fetus, so women who are pregnant or could become pregnant should avoid taking it, and breastfeeding mothers should also consider stopping breastfeeding or discontinuing the medication. Safety in children under 12 years old has not been established, and it should not be administered to them. This medication should be kept out of reach of children and should not be transferred to another container.

Gastrointestinal bleeding, serious cardiovascular thrombotic reactions, myocardial infarction, stroke, nausea, vomiting, photosensitivity, asthma attack, systemic weakness due to hypotension, anaphylactic shock, diarrhea, abdominal bloating, constipation, dyspepsia, ulcerative stomatitis, abdominal pain, hematemesis, colitis, exacerbation of Crohn's disease, elevated blood pressure, tachycardia, chest pain, arrhythmia, palpitations, hypotension, congestive heart failure, edema, hypertension, heart failure, vesicular reaction, Stevens-Johnson syndrome, Lyell syndrome, rash, urticaria, pruritus, purpura, dizziness, acute renal failure, interstitial nephritis, nephrotic syndrome, fluorine poisoning, abnormal liver tests, thrombocytopenia

This medication should be stored in a well-sealed container to prevent air from entering and is important to keep between 1 to 30 degrees Celsius at room temperature. By storing it this way, the medication's effectiveness can be maintained for a longer duration.

Appearance

Orange round film-coated tablet

Package unit

30 tablets/bottle, 500 tablets/bottle